TGF-α
Summary
TGF-α (Transforming Growth Factor-alpha) is a peptide growth factor that binds the epidermal growth factor receptor (EGFR/HER1) to stimulate epithelial cell proliferation and tissue development. It plays roles in normal wound healing and epithelial growth but is also implicated in tumorigenesis when overexpressed.
Detail
TGF-α is structurally related to EGF and shares the same receptor, EGFR (ErbB1/HER1), triggering downstream signaling cascades including the RAS-RAF-MEK-ERK (MAPK) pathway and PI3K-AKT pathway, promoting cell growth, proliferation, and differentiation. It is produced by keratinocytes, macrophages, and various epithelial cells, and plays a key role in normal skin and gastrointestinal epithelial development, as well as wound healing and tissue repair.
Clinically, TGF-α is significant in oncology: many epithelial cancers (e.g., hepatocellular carcinoma, renal cell carcinoma, breast cancer, and squamous cell carcinomas) show autocrine overexpression of TGF-α, which binds EGFR on the same or neighboring cells to drive uncontrolled proliferation—an example of autocrine signaling in tumorigenesis. Elevated TGF-α levels have also been associated with psoriasis due to excessive keratinocyte proliferation.
Understanding TGF-α is important for grasping concepts of growth factor signaling, EGFR pathway biology, and the rationale behind EGFR-targeted cancer therapies (e.g., cetuximab, erlotinib), even though these drugs primarily target the receptor rather than the ligand itself. It is a classic USMLE topic when discussing autocrine growth factor loops in cancer biology, alongside other factors like PDGF, VEGF, and IGF.
Sources
- First Aid for the USMLE Step 1
- Robbins and Cotran Pathologic Basis of Disease
- Lippincott Illustrated Reviews: Biochemistry
Reviewed by AnkiBoss editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.